News

The answer was on full display when the Vikings released their 2025-26 schedule with a 1-minute, 47-second video, featuring ...
The 61-year-old appeared on the Rich Eisen show this week and was asked about J.J. McCarthy and the Vikings being on the Chargers’ 2025 schedule. The date of the matchup has not been announced ...
As the legal battle continues over the fate of Kilmar Abrego García, President Donald Trump has repeatedly cited tattoos on the mistakenly deported man’s knuckles as proof that he is an MS-13 ...
The Minnesota Vikings raised eyebrows in the 2025 NFL Draft by skipping much-needed defensive help and selecting wide receiver Tai Felton. With an already crowded WR room and safety depth concerns ...
“Based on your time as a DEA agent in the field, particularly in Mexico, these tattoos are consistent with MS-13 associations?” asked Sen. Lindsey Graham (R-SC), holding up a picture of Abrego ...
Lindsey Graham, R-S.C., produced a photo of deported alleged gang member Kilmar Abrego Garcia and asked Cole to essentially translate the man’s controversial tattoos. "Are you familiar with MS-13?
The Minnesota Vikings and edge rusher Andrew Van Ginkel reached an agreement on Tuesday on a one-year, $23 million contract extension coming off his first Pro Bowl selection and a career-high 11 1 ...
Trump has posted what he claims to be an image of these tattoos to his Truth Social account. Here it is: You have perhaps noticed that these are not tattoos of the letters “MS-13.” But after ...
Altimmune and Viking Therapeutics have promising obesity drugs and could be great acquisition targets for Pfizer. Pfizer should be able to easily fund an acquisition of either small drugmaker.
Both Pfizer and Viking aim to enter the high-growth weight loss drug market. Analysts forecast this market could be worth as much as $130 billion just a few years from now. Big pharmaceutical ...
After letting Sam Darnold walk — despite leading them to a 14-3 season and throwing for 4,319 yards and 35 touchdowns — the Minnesota Vikings are all in on quarterback J.J. McCarthy.
Shares of Viking Therapeutics (NASDAQ: VKTX) jumped 12.5% through 11:40 a.m. ET on Tuesday on further support from Wall Street analysts. Seedhouse doesn't beat around the bush: "Our thesis is ...